{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:30:55Z","timestamp":1786408255152,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a common and severe complication after cardiac surgery with cardiopulmonary bypass (CPB). Experimental data suggest that increasing CPB flow beyond standard targets may improve renal oxygenation, but clinical evidence is limited. We hypothesized that increasing CPB flow would attenuate renal injury and improve organ perfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      In this single-center, randomized controlled trial, 89 adults undergoing elective cardiac surgery were allocated to either high-flow (2.9 L\u00b7min\u00b7m\n                      <jats:sup>\u22122<\/jats:sup>\n                      ) or standard-flow (2.4 L\u00b7min\u00b7m\n                      <jats:sup>\u22122<\/jats:sup>\n                      ) during CPB. Mean arterial pressure (MAP) was maintained at 60 to 80 mm Hg by use of norepinephrine. Primary outcomes were urine biomarkers of renal injury;\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acetyl-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucoseaminidase (NAG) and tissue inhibitor of metalloproteinase-2 \u00d7 insulin-like growth factor binding protein-7 [TIMP-2 \u00d7 IGFBP-7] levels at 60 minutes post-CPB. Additional outcomes included serum creatinine changes, AKI incidence, perioperative norepinephrine dose, and fluid balance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      High-flow significantly reduced renal injury biomarkers compared to standard-flow, geometric mean ratio for NAG: 0.43; 95% confidence interval (CI), 0.26 to 0.70,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001, and [TIMP-2 \u00d7 IGFBP-7]: 0.46; 95% CI, 0.30 to 0.73;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001. Median S-creatinine remained below baseline for the first three postoperative days in the high-flow group, and above baseline in the standard-flow group. AKI incidence was 16% (7\/45) in the high-flow group vs 25% (11\/44) in the standard-flow group, odds ratio 1.90; 95% CI, 0.64 to 5.60,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .248. Norepinephrine doses were significantly reduced in the high-flow-group, both intraoperatively and up until 4 hours after CPB. There were no significant differences in fluid balance, bleeding, or adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Increasing CPB flow by 20% reduced renal injury biomarkers and postoperative creatinine and improved early hemodynamic stability. Further large-scale, multicenter trials are required to validate these findings and determine patient subgroups most likely to benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000008196","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:08Z","timestamp":1786406408000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Elevated Cardiopulmonary Bypass Flow for Renal Protection in Cardiac Surgery: A Randomized Trial"],"prefix":"10.1213","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2069-9996","authenticated-orcid":false,"given":"Johanna","family":"Wijk","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Section of Cardiothoracic Anaesthesia and Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Corderfeldt-Keiller","sequence":"additional","affiliation":[{"name":"Department of Perfusion, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Redfors","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Section of Cardiothoracic Anaesthesia and Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Lannemyr","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Section of Cardiothoracic Anaesthesia and Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"R1-20260810","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"R2-20260810","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.athoracsur.2012.10.024","article-title":"Lung injury and acute respiratory distress syndrome after cardiac surgery.","volume":"95","author":"Stephens","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R3-20260810","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/ALN.0b013e318210f86a","article-title":"Cardiopulmonary bypass\u2013associated acute kidney injury.","volume":"114","author":"Kumar","year":"2011","journal-title":"Anesthesiology"},{"key":"R4-20260810","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.jvca.2015.06.017","article-title":"Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis.","volume":"30","author":"Hu","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R5-20260810","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jtcvs.2013.06.049","article-title":"Prediction of acute kidney injury within 30 days of cardiac surgery.","volume":"147","author":"Ng","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-20260810","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtcvs.2020.01.101","article-title":"Costs and consequences of acute kidney injury after cardiac surgery: a cohort study.","volume":"162","author":"Lau","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R7-20260810","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1051\/ject\/201749224","article-title":"Low oxygen delivery as a predictor of acute kidney injury during cardiopulmonary bypass.","volume":"49","author":"Newland","year":"2017","journal-title":"J Extra Corpor Technol"},{"key":"R8-20260810","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jtcvs.2018.04.045","article-title":"Goal-directed perfusion to reduce acute kidney injury: a randomized trial.","volume":"156","author":"Ranucci","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R9-20260810","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.athoracsur.2023.04.049","article-title":"Oxygen delivery thresholds during cardiopulmonary bypass and risk for acute kidney injury.","volume":"116","author":"Do-Nguyen","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"R10-20260810","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.kint.2019.01.032","article-title":"Strategies that improve renal medullary oxygenation during experimental cardiopulmonary bypass may mitigate postoperative acute kidney injury.","volume":"95","author":"Lankadeva","year":"2019","journal-title":"Kidney Int"},{"key":"R11-20260810","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.athoracsur.2018.08.085","article-title":"Impact of cardiopulmonary bypass flow on renal oxygenation in patients undergoing cardiac operations.","volume":"107","author":"Lannemyr","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R12-20260810","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1053\/j.jvca.2022.05.023","article-title":"The effects of targeted changes in systemic blood flow and mean arterial pressure on urine oximetry during cardiopulmonary bypass.","volume":"36","author":"Hu","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R13-20260810","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/ALN.0000000000005648","article-title":"Effects of increased cardiopulmonary bypass pump flow on renal filtration, perfusion, oxygenation, and tubular injury in cardiac surgical patients: a randomized controlled trial.","volume":"143","author":"Wijk","year":"2025","journal-title":"Anesthesiology"},{"key":"R14-20260810","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1053\/j.jvca.2024.07.017","article-title":"Standard versus high cardiopulmonary bypass flow rate: a randomized controlled subtrial comparing brain injury biomarker release.","volume":"38","author":"Keiller","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R15-20260810","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R16-20260810","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury.","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R17-20260810","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/aas.13975","article-title":"Dextran-based priming solution during cardiopulmonary bypass attenuates renal tubular injury\u2014a secondary analysis of randomized controlled trial in adult cardiac surgery patients.","volume":"66","author":"Kolsrud","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"R18-20260810","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/ALN.0000000000001461","article-title":"Effects of cardiopulmonary bypass on renal perfusion, filtration, and oxygenation in patients undergoing cardiac surgery.","volume":"126","author":"Lannemyr","year":"2017","journal-title":"Anesthesiology"},{"key":"R19-20260810","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jtcvs.2021.03.032","article-title":"Oxygen delivery-guided perfusion for the prevention of acute kidney injury: a randomized controlled trial.","volume":"165","author":"Mukaida","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-20260810","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.ajkd.2015.06.018","article-title":"Urinary, plasma, and serum biomarkers\u2019 utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis.","volume":"66","author":"Ho","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R21-20260810","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/IJNRD.S198222","article-title":"Evaluating Nephrocheck\u00ae as a predictive tool for acute kidney injury.","volume":"13","author":"Nalesso","year":"2020","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"R22-20260810","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000479298","article-title":"TIMP-2*IGFBP7 (Nephrocheck\u00ae) Measurements at intensive care unit admission after cardiac surgery are predictive for acute kidney injury within 48 hours.","volume":"42","author":"Oezkur","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"R23-20260810","doi-asserted-by":"crossref","first-page":"1257631","DOI":"10.3389\/fphys.2024.1257631","article-title":"Higher perfusion pressure and pump flow during cardiopulmonary bypass are beneficial for kidney function\u2014a single-centre prospective study.","volume":"15","author":"Udzik","year":"2024","journal-title":"Front Physiol"},{"key":"R24-20260810","doi-asserted-by":"crossref","first-page":"1224068","DOI":"10.3389\/fsurg.2024.1224068","article-title":"Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.","volume":"11","author":"Banerjee","year":"2024","journal-title":"Front Surg"},{"issue":"suppl 10","key":"R25-20260810","doi-asserted-by":"crossref","first-page":"S1489","DOI":"10.21037\/jtd.2019.02.100","article-title":"Monitoring and optimization of the microcirculation during CPB.","volume":"11","author":"Murkin","year":"2019","journal-title":"J Thorac Dis"},{"key":"R26-20260810","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/rccm.202005-2050OC","article-title":"Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients.","volume":"203","author":"K\u00fcllmar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20260810","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezaf340","article-title":"Inadequate oxygen delivery during cardiopulmonary bypass drives inflammatory reaction after cardiac surgery.","volume":"67","author":"Squiccimarro","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"key":"R28-20260810","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/jcan.2001.26550","article-title":"Pro: low-flow cardiopulmonary bypass is the preferred technique for patients undergoing cardiac surgical procedures.","volume":"15","author":"DiNardo","year":"2001","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R29-20260810","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bja.2025.01.015","article-title":"EACTS\/EACTAIC\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery.","volume":"134","author":"Wahba","year":"2025","journal-title":"Br J Anaesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:11Z","timestamp":1786406411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000008196","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}